Hospital Injectable Drugs Market

Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
Hospital Injectable Drugs Market contains market size and forecasts of Hospital Injectable Drugs in Global, including the following market information:
Global Hospital Injectable Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital Injectable Drugs market was valued at 41580 million in 2021 and is projected to reach US$ 56940 million by 2028, at a CAGR of 4.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Sterile Injectables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital Injectable Drugs include Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy?s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent) and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Injectable Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital Injectable Drugs Market Segment Percentages, by Type, 2021 (%)
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Global Hospital Injectable Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hospital Injectable Drugs Market Segment Percentages, by Application, 2021 (%)
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Global Hospital Injectable Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hospital Injectable Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Injectable Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hospital Injectable Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy?s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane